About Us   |   Contact Us
An International Publisher for Academic and Scientific Journals
Author Login 
 Author Login
Submit Manuscript
Join Membership
Join As Reviewer
Join As Editor
Pay Publication Fee
Subscribe Hard Copy
SAS Journal of Medicine | Volume-8 | Issue-02
Gastrointestinal Adverse Events Associated with Immune Checkpoint Inhibitor Therapy
Lamia Aalaoui, Mohamed Reda Khmamouche, Mohamed Anouar Mokhlis, RachidTanz, Hassan Errihani, Mohamed Ichou
Published: Feb. 13, 2022 | 133 116
DOI: 10.36347/sasjm.2022.v08i02.005
Pages: 79-84
Downloads
Abstract
The introduction of immune checkpoint inhibitors (ICIs) has significantly improved cancer management and survival outcomes .One third of patients exposed to ICI will develop gastrointestinal adverse events (GIAEs). Knowledge of these toxicities, along with effective management algorithms, is essential to enable early diagnosis and treatment, decreasing morbidity and mortality.